WO2011023629A1 - Dispositif d'injection - Google Patents

Dispositif d'injection Download PDF

Info

Publication number
WO2011023629A1
WO2011023629A1 PCT/EP2010/062151 EP2010062151W WO2011023629A1 WO 2011023629 A1 WO2011023629 A1 WO 2011023629A1 EP 2010062151 W EP2010062151 W EP 2010062151W WO 2011023629 A1 WO2011023629 A1 WO 2011023629A1
Authority
WO
WIPO (PCT)
Prior art keywords
thread
stopper
injection device
compartment
longitudinal axis
Prior art date
Application number
PCT/EP2010/062151
Other languages
English (en)
Inventor
Thomas Nagel
René RICHTER
Robert Witt
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Priority to CA2771159A priority Critical patent/CA2771159A1/fr
Publication of WO2011023629A1 publication Critical patent/WO2011023629A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • A61M5/31515—Connection of piston with piston rod
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod

Definitions

  • the present invention relates to an injection device with a compartment for a substance to be dispensed by means of the injection device and a stopper sealing the compartment.
  • the substance to be dispensed may be a drug or a medicament.
  • DE 10 2007 047 346 A1 discloses a syringe comprising a piston and a cylinder movable against each other in a direction of an axis of the syringe by the operation of an outer rotatable thread casing.
  • US 6004297 discloses an injection syringe for apportioning set doses of a medicine from a cartridge containing an amount of medicine sufficient for the preparation of a number of therapeutic doses.
  • the injection syringe comprises a housing; a piston rod having a not circular cross-section and an outer thread, and a piston rod drive.
  • the piston rod drive comprises a piston rod guide mating the not circular cross-section of the piston rod to allow axially displacement but not rotation of the piston rod in relation to said piston rod guide, and a nut member which is not axially displaceable in the housing and which has an inner thread mating the thread of the piston rod to form a self locking thread connection.
  • EP 2 050 477 A1 discloses an injection device with a compartment for a substance to be dispensed by means of the injection device and a stopper sealing the compartment.
  • a piston rod comprises a first thread which cooperates with a complementary second thread of another component of the injection device, such that the stopper moves along a longitudinal axis of the injection device when the first thread and the second thread are rotated relatively to one another and thereby urges a substance contained in the compartment to be dispensed.
  • US 5 618 273 A discloses an injection device with a compartment for a substance to be dispensed by means of the injection device and a stopper sealing the compartment.
  • a piston rod comprises a first thread which cooperates with a complementary second thread of another component of the injection device, such that the stopper moves along a longitudinal axis of the injection device when the first thread and the second thread are rotated relatively to one another and thereby urges a substance contained in the compartment to be dispensed.
  • EP 1 754 498 A1 discloses a drive arrangement for advancing a stopper in an ampoule.
  • the drive arrangement comprises an advancing element composed of single members, who are consecutively inserted into the ampoule through a diverting area. The members may be threaded.
  • EP 1 974 760 A1 discloses an injection device with a compartment for a substance to be dispensed by means of the injection device and a stopper sealing the compartment.
  • the stopper comprises a first thread which cooperates with a complementary second thread of another component of the injection device, such that the stopper moves along a longitudinal axis of the injection device when the first thread and the second thread are rotated relatively to one another and thereby urges a substance contained in the compartment to be dispensed.
  • the Stopper has an essentially cylindrical opening and the first thread is an internal thread on the surface of the opening.
  • the object is achieved by an injection device according to claim 1.
  • Preferred em bod i merits of the invention are given in the dependent claims.
  • an injection device with a compartment for a substance to be dispensed, for example a drug or a medicament, by means of the injection device and a stopper sealing the compartment.
  • the stopper comprises a first thread which cooperates with a complementary second thread of another component of the injection device, such that the stopper moves along a longitudinal axis of the injection device when the first thread and the second thread are rotated relatively to one another and thereby urges a substance contained in the com- partment to be dispensed.
  • the cooperation of the first and the second thread thus allows the stopper to be moved along the longitudinal axis by rotating these threads relative to one another in order to dispense the substance. This has several advantages as compared to stan- dard translational movement of a stopper.
  • a first advantage is that the amount of the substance to be dispensed can be very accurately dosed as a function of the angle of the relative rotation of the threads.
  • a second advantage is that the effects of an accidental release of the injection device causing dispensing of substance are reduced, since large translational motions of the stopper are much easier caused by forces acting directly in the direction of the translation than indirectly via a relative rotation of the two threads.
  • An important third advantage of moving the stopper translationally by relative rotation of the two threads is that it avoids, or at least substantially reduces, a so-called stick- slip-effect caused by the friction between an outer surface of the stopper and an inner surface of a wall of the compartment for the substance. Typically, the static friction between these two surfaces exceeds the kinetic friction.
  • a fourth advantage is that by moving the stopper translationally by relative rotation of the two threads, the stopper is less exposed to forces tending to compress it in the direction of the translational motion than by exerting to it a force directly in the transla- tional direction. This reduces the compression of the stopper in the direction of its translational motion and the danger of its subsequent expansion during its translational motion which can influence the dose of the substance to be dispensed by the injection device in an undesirable and uncontrollable manner. In particular this further improves the dose accuracy of the injection device. Furthermore, the undesirable stick-slip-effect is reduced.
  • At least one of the two threads is coated with a deformable coating sealing a contact area of the first thread and the second thread to prevent the substance from pervading the contact area.
  • a deformable coating of one of the threads provides an efficient and simple means to prevent the substance from pervading the contact area since the contact pressure between cooperating pitches of the two threads will deform the coating so that it seals the contact area of the threads.
  • the inventionjhe stopper has an essentially cylindrical outer surface whose cylinder axis lies on the longitudinal axis of the injection device and the first thread is an external thread on this outer surface.
  • the compartment for the substance has a cylindrical inner surface corresponding to the outer surface of the stopper and the second thread is a structure on the inner surface of the compartment for the substance.
  • the corresponding cylindrical shapes of the outer surface of the stopper and the inner surface of the compartment with cooperating threads allow advantageously a rotation of these threads relative to one another causing a translational motion of the stopper along the longitudinal axis of the injection device.
  • the injection device ac- cording to the invention allows one to make the stopper out of a comparatively firm material since the stopper itself need not be elastic in order to the seal the compartment, as the contact area of the thread is sealed by the deformable coating.
  • the use of a firm stopper has the advantage that the stopper is less compressed by the internal pressure in the compartment which improves the dose accuracy, as explained above.
  • the stopper is preferentially firmly connected in a force-fitting and/or form-fitting and/or integrally joined manner to a rod member which extends from the stopper along the longitudinal axis of the injection device.
  • a firm connection of the stopper to a rod member which extends from the stopper along the longitudinal axis of the injection device has the advantage that the stopper can be rotated around the longitudinal axis of the injection device by rotating the rod member around its longitudinal axis.
  • the stopper has an essentially cylindrical opening and the first thread is an internal thread on the surface of the opening.
  • the stopper is preferentially coupled to a rod member which extends along the longitudinal axis of the injection device and has a cylindrical section corresponding to the opening in the stopper and the second thread is an external thread on this section.
  • the stopper rotates relative to the rod member, without necessarily rotating relative to the compartment for the substance. Therefore, in this embodiment the outer surface of the stopper and the inner surface of the compartment wall need not be of cylindrical shape. In fact, they may have, for instance, rectangular cross sections in a plane orthogonal to the longitudinal axis of the injection device. This may be advantageous for uses of the injection device where a non-cylindrical shape of the injection device is better suited than a cylindrical shape. For instance, when a medical syringe is used within the injection device, the syringe normally needs to be prevented from rotating within the injection device and that can be easily achieved when the injection device has a rectangular cross section.
  • the injection device preferentially comprises fixing means preventing the rod member to move along the longitudinal axis of the injection device.
  • Such fixing means thus fix the position of the rod member relative to the compartment for the substance.
  • This has the advantage that the translational motion of the stopper is controlled solely by the rotation of the rod member around its longitudinal axis, and not additionally by the translational motions of the rod member.
  • the injection device comprises preferentially bearing means constraining the position of the rod member to the longitudinal axis of the injection device and allowing the rod member to rotate around the longitudinal axis of the injection device.
  • Such bearing means advantageously stabilize the position of the rod member and thus facilitate and improve the use of the injection device. Furthermore they prevent misuse of the injection device caused by tilting the rod member relative to the longitudinal axis of the injection device which may damage the injection device.
  • the injection device comprises preferentially stopping means preventing the stopper from leaving the compartment for the substance.
  • Such stopping means prevent advantageously the substance from leaking accidentally from the compartment by restraining the stopper from leaving the compartment.
  • An injection device according to the invention is particularly suited to be used in a pen injector.
  • Fig. 1 illustrates schematically a longitudinal section of a first embodiment of an injec- tor comprising a stopper with an external thread
  • Fig. 2 illustrates schematically a longitudinal section of a non-inventive second embodiment of an injection device comprising a stopper with an internal thread.
  • Figure 1 illustrates schematically a longitudinal section of a first embodiment of an injection device 1 according to the invention.
  • the injection device 1 comprises a compartment 2 for a substance to be dispensed, for example a drug or a medicament, by means of the injection device 1 , a stopper 3 sealing the compartment 2, a rod mem- ber 4 firmly connected to the stopper 3, and a closure head 5.
  • the stopper 3 is of cylindrical shape and comprises a first thread 6 formed as an external thread on its outer surface.
  • the cylinder axis of the stopper 3 lies on a longitudinal axis A of the injection device 1.
  • the compartment 2 is also of cylindrical shape and has an inner cylinder diameter that corresponds to the cylinder diameter of the stopper 3.
  • the compartment 2 has a second thread 7 on its inner surface.
  • the second thread 7 corresponds to the first thread 6 on the outer surface of the stopper 3 and cooperates with the latter so that the stopper 3 moves along the longitudinal axis A when it is rotated around the longitudinal axis A.
  • the compartment 2 comprises a conical nozzle 8 through which a substance contained in the compartment 2 can be dispensed and which extends from a central area of a bottom surface 9 of the compartment 2.
  • the first thread 6 is coated with a deformable coating 10 sealing a contact area of the first thread 6 and the second thread 7 to prevent a substance contained in the compartment 2 from pervading the contact area.
  • the rod member 4 extends from the stopper 3 along the longitudinal axis A out of the compartment 2 so that it can be used to rotate the stopper 3 from the outside of the compartment 2 by rotating the rod member 4 around its longitudinal axis.
  • the closure head 5 closes the compartment 2 at a top side and is firmly connected to a top edge 11 of a side wall 12 of the compartment 2. It comprises a recess 13 for the rod member 4 which extends through this recess 13.
  • the closure head 5 serves as stopping means preventing the stopper 3 from leaving the compartment 2 and the recess 13 serves as bearing means constraining the position of the rod member 4 to the longitudinal axis A and allowing the rod member 4 to rotate around the longitudinal axis A.
  • FIG. 2 illustrates schematically a longitudinal section of a non-inventive second embodiment of an injection device 1 according to the invention.
  • the injection device 1 comprises a compartment 2 for a substance to be dispensed by means of the injection device 1 , a stopper 3 sealing the compartment 2, a rod member 4 coupled to the stopper 3, and a closure head 5.
  • the compartment 2 is of cylindrical shape and has a flat inner surface. As in the first embodiment it comprises a conical nozzle 8 through which a substance contained in the compartment 2 can be dispensed and which extends from a bottom surface 9 of the compartment 2. However, the nozzle 8 now does not extend from a central area of the bottom surface 9 but from an area closer to a circumference of the bottom surface 9.
  • the stopper 3 is also of cylindrical shape with a cylinder diameter that corresponds to the inner cylinder diameter of the compartment 2.
  • the stopper 3 features a cylindrical opening 14 in a central area around a longitudinal axis A of the injection device 1 and a first thread 6 which is formed as an internal thread on the surface of the opening 14.
  • the cylindrical outer surface of the stopper 3 is flat and made out of an elastic material which contacts the inner surface of the compartment 2, thereby retaining a sub- stance contained in the compartment 2 to pervade a contact area of the stopper 3 and the inner surface of the compartment 2.
  • the closure head 5 is formed and located as in the first embodiment illustrated in fig- ure 1. In particular it features a recess 13 for the rod member 4.
  • the rod member 4 is of cylindrical shape with a cylinder diameter corresponding to the cylinder diameter of the opening 14 in the stopper 3. It comprises a second thread 7 which is formed as an external thread on its surface. The second thread 7 corre- sponds to the first thread 6 on the surface of the opening 14 in the stopper 3 and cooperates with the first thread 6 so that the stopper 3 moves along the longitudinal axis A when the rod member 4 is rotated around the longitudinal axis A.
  • the first thread 6 is coated with a deformable coating 10 sealing a contact area of the first thread 6 and the second thread 7 to prevent a substance contained in the compartment 2 from pervading this contact area.
  • the rod member 4 extends from a cavity 15 in a bottom wall 16 through the opening 14 in the stopper 3 and through the recess 13 in the closure head 5 out of the compartment 2.
  • the cavity 15 is ball-shaped with a maximal cross-section in the interior of the bottom wall 16. It mounts an end piece 17 of the rod member 4 of corresponding shape and size so that the end piece 17 can rotate around the longitudinal axis A but cannot leave the cavity 15.
  • the cavity 15 thus serves both as fixing means preventing the rod member 4 to move along the longitudinal axis A of the injection device 1 and, in cooperation with the recess 13 in the closure head 5 and the opening 14 in the stopper 3, as bearing means constraining the position of the rod member 4 to the longitudinal axis A and allowing the rod member 4 to rotate around the longitudinal axis A.
  • the compartment 2 and the rod member 4 are made out of glass or plastics, e.g. as injection moulding parts
  • the stopper 3 and the closure head 5 are made out of plastics, e.g. as injection moulding parts.
  • drug or “medicament” means a pharmaceutical formulation containing at least one pharmaceutically active compound, wherein in one embodiment the pharmaceutically active compound has a molecular weight up to 1500 Da and/or is a peptide, a proteine, a polysaccharide, a vaccine, a DNA, a RNA, a antibody, an enzyme, an antibody, a hormone or an oligonucleotide, or a mixture of the above-mentioned pharmaceutically active compound, wherein in a further embodiment the pharmaceutically active compound is useful for the treatment and/or prophylaxis of diabetes mellitus or complications associated with diabetes mellitus such as diabetic retinopathy, thromboembolism disorders such as deep vein or pulmonary thromboembolism, acute coronary syndrome (ACS), angina, myocardial infarction, cancer, macular degeneration, inflammation, hay fever, atherosclerosis and/or rheumatoid arthritis, wherein in a further embodiment the
  • Lys(B3) Glu(B29) human insulin; Lys(B28), Pro(B29) human insulin; Asp(B28) human insulin; human insulin, wherein proline in position B28 is replaced by Asp, Lys, Leu, VaI or Ala and wherein in position B29 Lys may be replaced by Pro; Ala(B26) human insulin; Des(B28-B30) human insulin; Des(B27) human insulin and Des(B30) human insulin.
  • Insulin derivates are for example B29-N-myhstoyl-des(B30) human insulin; B29-N- palmitoyl-des(B30) human insulin; B29-N-myristoyl human insulin; B29-N-palmitoyl human insulin; B28-N-myristoyl LysB28ProB29 human insulin; B28-N-palmitoyl- LysB28ProB29 human insulin; B30-N-myhstoyl-ThrB29LysB30 human insulin; B30-N- palmitoyl- ThrB29LysB30 human insulin; B29-N-(N-palmitoyl-Y-glutamyl)-des(B30) human insulin; B29-N-(N-lithocholyl-Y-glutamyl)-des(B30) human insulin; B29-N-( ⁇ - carboxyheptadecanoyl)-des(B30) human insulin and B29-N-( ⁇ -
  • Exendin-4 for example means Exendin-4(1 -39), a peptide of the sequence H His-Gly- Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu- Phe-lle-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2.
  • Exendin-4 derivatives are for example selected from the following list of compounds:
  • Hormones are for example hypophysis hormones or hypothalamus hormones or regu- latory active peptides and their antagonists as listed in Rote Liste, ed. 2008, Chapter 50, such as Gonadotropine (Follitropin, Lutropin, Choriongonadotropin, Menotropin), Somatropine (Somatropin), Desmopressin, Terlipressin, Gonadorelin, Triptorelin, Le- uprorelin, Buserelin, Nafarelin, Goserelin.
  • Gonadotropine Follitropin, Lutropin, Choriongonadotropin, Menotropin
  • Somatropine Somatropin
  • Desmopressin Terlipressin
  • Gonadorelin Triptorelin
  • Le- uprorelin Buserelin
  • Nafarelin Goserelin.
  • a polysaccharide is for example a glucosaminoglycane, a hyaluronic acid, a heparin, a low molecular weight heparin or an ultra low molecular weight heparin or a derivative thereof, or a sulphated, e.g. a poly-sulphated form of the above-mentioned polysaccharides, and/or a pharmaceutically acceptable salt thereof.
  • An example of a pharmaceutically acceptable salt of a poly-sulphated low molecular weight heparin is enoxa- parin sodium.
  • Pharmaceutically acceptable salts are for example acid addition salts and basic salts. Acid addition salts are e.g. HCI or HBr salts.
  • Basic salts are e.g. salts having a cation selected from alkali or alkaline, e.g. Na+, or K+, or Ca2+, or an ammonium ion
  • R1 to R4 independently of each other mean: hydrogen, an optionally substituted C1 C6-alkyl group, an optionally substituted C2-C6-alkenyl group, an optionally substituted C6-C10-aryl group, or an optionally substituted C6- C10-heteroaryl group.
  • R1 to R4 independently of each other mean: hydrogen, an optionally substituted C1 C6-alkyl group, an optionally substituted C2-C6-alkenyl group, an optionally substituted C6-C10-aryl group, or an optionally substituted C6- C10-heteroaryl group.
  • solvates are for example hydrates.

Abstract

L'invention concerne un dispositif d'injection (1) muni d'un compartiment (2) permettant de distribuer une substance au moyen du dispositif d'injection (1), et d'une butée (3) scellant le compartiment (2). La butée (3) comprend un premier filetage (6) qui coopère avec un second filetage complémentaire (7) d'un autre composant (2, 4) du dispositif d'injection (1), de sorte que la butée (3) se déplace sur un axe longitudinal (A) du dispositif d'injection (1) lorsque le premier filetage (6) et le second filetage (7) sont tournés l'un par rapport à l'autre et force ainsi une substance contenue dans le compartiment (2) à être distribuée.
PCT/EP2010/062151 2009-08-27 2010-08-20 Dispositif d'injection WO2011023629A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2771159A CA2771159A1 (fr) 2009-08-27 2010-08-20 Dispositif d'injection

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09010970.3 2009-08-27
EP09010970 2009-08-27

Publications (1)

Publication Number Publication Date
WO2011023629A1 true WO2011023629A1 (fr) 2011-03-03

Family

ID=41434766

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/062151 WO2011023629A1 (fr) 2009-08-27 2010-08-20 Dispositif d'injection

Country Status (2)

Country Link
CA (1) CA2771159A1 (fr)
WO (1) WO2011023629A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016134221A1 (fr) * 2015-02-20 2016-08-25 Regeneron Pharmaceuticals, Inc. Systèmes de seringue, systèmes de joint d'étanchéité de piston, systèmes de butée et procédés d'utilisation et d'assemblage
WO2020008360A1 (fr) * 2018-07-02 2020-01-09 Edelweiss Dr Ag Dispositif d'extrusion et système d'administration de composite
US11400225B2 (en) 2017-05-11 2022-08-02 Novo Nordisk A/S Piston rod brake mechanism

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2590494A (en) * 2019-12-20 2021-06-30 Maguire Kevin A dispensing device

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2349726A (en) 1942-06-18 1944-05-23 George J Holler Dispenser for extrusile substances
US3082914A (en) 1958-11-06 1963-03-26 Gill Wilbur Dispensing device
US5618273A (en) 1995-03-27 1997-04-08 Ultradent Product, Inc. Syringe apparatus with threaded plunger for delivering tooth composites and other solid yet pliable materials
US6004297A (en) 1998-01-30 1999-12-21 Novo Nordisk A/S Injection syringe
US20050156981A1 (en) * 2004-01-21 2005-07-21 Silverbrook Research Pty Ltd. Method of refilling a high speed print engine
EP1754498A1 (fr) 2005-08-19 2007-02-21 Roche Diagnostics GmbH Dispositif d'entraînement pour un dispositif d'injection ou de perfusion
EP1974760A1 (fr) 2007-03-29 2008-10-01 Jürgen Schmidt-Evers Pen-Injecteur par un injection liquide, particulier insulin
DE102007047346A1 (de) 2007-10-04 2009-04-09 Kai Parthy Spritze mit Dosier-Adapter
EP2050477A1 (fr) 2007-10-19 2009-04-22 F.Hoffmann-La Roche Ag Unité d'ampoule dotée d'un adaptateur

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2349726A (en) 1942-06-18 1944-05-23 George J Holler Dispenser for extrusile substances
US3082914A (en) 1958-11-06 1963-03-26 Gill Wilbur Dispensing device
US5618273A (en) 1995-03-27 1997-04-08 Ultradent Product, Inc. Syringe apparatus with threaded plunger for delivering tooth composites and other solid yet pliable materials
US6004297A (en) 1998-01-30 1999-12-21 Novo Nordisk A/S Injection syringe
US20050156981A1 (en) * 2004-01-21 2005-07-21 Silverbrook Research Pty Ltd. Method of refilling a high speed print engine
EP1754498A1 (fr) 2005-08-19 2007-02-21 Roche Diagnostics GmbH Dispositif d'entraînement pour un dispositif d'injection ou de perfusion
EP1974760A1 (fr) 2007-03-29 2008-10-01 Jürgen Schmidt-Evers Pen-Injecteur par un injection liquide, particulier insulin
DE102007047346A1 (de) 2007-10-04 2009-04-09 Kai Parthy Spritze mit Dosier-Adapter
EP2050477A1 (fr) 2007-10-19 2009-04-22 F.Hoffmann-La Roche Ag Unité d'ampoule dotée d'un adaptateur

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016134221A1 (fr) * 2015-02-20 2016-08-25 Regeneron Pharmaceuticals, Inc. Systèmes de seringue, systèmes de joint d'étanchéité de piston, systèmes de butée et procédés d'utilisation et d'assemblage
KR20170118111A (ko) * 2015-02-20 2017-10-24 리제너론 파아마슈티컬스, 인크. 주사기 시스템, 피스톤 시일 시스템, 스토퍼 시스템 및 사용 방법 및 조립체
US10869966B2 (en) 2015-02-20 2020-12-22 Regeneron Pharmaceuticals, Inc. Syringe systems, piston seal systems, stopper systems, and methods of use and assembly
KR102541205B1 (ko) 2015-02-20 2023-06-09 리제너론 파아마슈티컬스, 인크. 주사기 시스템, 피스톤 시일 시스템, 스토퍼 시스템 및 사용 방법 및 조립체
US11400225B2 (en) 2017-05-11 2022-08-02 Novo Nordisk A/S Piston rod brake mechanism
WO2020008360A1 (fr) * 2018-07-02 2020-01-09 Edelweiss Dr Ag Dispositif d'extrusion et système d'administration de composite
CH715144A1 (fr) * 2018-07-02 2020-01-15 Edelweiss Dr Ag Dispositif d’extrusion et système de distribution de composite.

Also Published As

Publication number Publication date
CA2771159A1 (fr) 2011-03-03

Similar Documents

Publication Publication Date Title
EP2493532B1 (fr) Dispositif d'administration de médicaments
US9067018B2 (en) Cartridge holder assembly for a drug delivery device
AU2010332862B2 (en) Piston for a cartridge and piston rod for a drug delivery device
US9750890B2 (en) Mechanism for a drug delivery device
WO2010112563A1 (fr) Dispositif médical comprenant un mécanisme et utilisation d'un matériau synthétique à frottement réduit dans un dispositif médical
US9345832B2 (en) Cartridge holder and drug delivery device
CA2813130A1 (fr) Ensemble capuchon pour un dispositif d'administration de medicament
WO2011023629A1 (fr) Dispositif d'injection
EP2731650B1 (fr) Mécanisme d'entraînement d'un dispositif d'administration de médicament
US8998857B2 (en) Cartridge holder assembly for a drug delivery device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10745239

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2771159

Country of ref document: CA

Ref document number: 2010745239

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012526016

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: JP